We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Polarean Imaging Plc | LSE:POLX | London | Ordinary Share | GB00BF3DT583 | ORD GBP0.00037 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.05 | -2.67% | 1.825 | 5,377,298 | 12:51:05 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 1.80 | 1.85 | 1.90 | 1.825 | 1.875 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Surgical,med Instr,apparatus | USD 1.03M | USD -13.91M | USD -0.0115 | -1.58 | 22.63M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:19:31 | O | 15,000 | 1.806 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 26/7/2024 | 07:00 | UK RNS | Polarean Imaging PLC Block Listing Six Monthly Return |
| 24/7/2024 | 14:36 | UK RNS | Polarean Imaging PLC Result of AGM |
| 19/7/2024 | 19:34 | ALNC |  TRADING UPDATES: Ingenta and Shearwater win deals |
| 19/7/2024 | 10:36 | UK RNS | Polarean Imaging PLC Xenon MRI System trade-in agreement |
| 18/7/2024 | 17:33 | UK RNS | Polarean Imaging PLC PDMR Dealing |
| 28/6/2024 | 19:46 | ALNC | EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows |
| 28/6/2024 | 07:00 | UK RNS | Polarean Imaging PLC Final Results |
| 19/6/2024 | 17:23 | UK RNS | Polarean Imaging PLC Holding(s) in Company |
| 19/6/2024 | 17:23 | UK RNS | Polarean Imaging PLC Holding(s) in Company |
| 19/6/2024 | 16:10 | UK RNS | Polarean Imaging PLC Holding(s) in Company |
Polarean Imaging (POLX) Share Charts1 Year Polarean Imaging Chart |
|
1 Month Polarean Imaging Chart |
Intraday Polarean Imaging Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 25/7/2024 | 11:35 | Polarean Imaging PLC | 7,523 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-07-26 15:19:32 | 1.81 | 15,000 | 270.90 | O |
| 2024-07-26 15:10:17 | 1.81 | 167,356 | 3,022.45 | O |
| 2024-07-26 14:43:56 | 1.85 | 125,000 | 2,308.13 | O |
| 2024-07-26 14:35:11 | 1.80 | 767 | 13.81 | O |
| 2024-07-26 14:30:11 | 1.80 | 55,000 | 990.55 | O |
| Top Posts |
|---|
Posted at 26/7/2024 09:20 by Polarean Imaging Daily Update Polarean Imaging Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker POLX. The last closing price for Polarean Imaging was 1.88p.Polarean Imaging currently has 1,207,032,781 shares in issue. The market capitalisation of Polarean Imaging is £21,967,997. Polarean Imaging has a price to earnings ratio (PE ratio) of -1.58. This morning POLX shares opened at 1.88p |
Posted at 19/7/2024 11:09 by fft Errr. POLX are buying the older machines and selling them the newer ones. There is no mention of how much POLX are paying for them, and I suspect it is higher than the price POLX will get when they try and sell them again !This seems like a loss leader to get influential people involved. Note, there is no quote from the Virginia people saying how they always wanted the POLX kit. Indeed, unless I have looked at a wrong version of the RNS there is no quote at all In other words POLX are probably losing money on this deal and if other sites see this they may also like to do a trade in, but the more that do it the worse for POLX cash flow. My 2 cents |
Posted at 16/7/2024 08:43 by kingston78 POLX is on an upward move. It is going to break the 2 p level soon. The low placing price was forced upon the company due to market conditions. In better times it could have raised money at 3 or 4 p when its share price was at 5 p, which dropped like a stone.It has a world-first device used in hospitals in the US. All it needs is to expand the sales network in the US and other countries. Management should capitalise on the company's invention quickly. |
Posted at 10/7/2024 21:12 by goldbutler ' a committed board .... their own money into 'in 2023 the Board took $1,266,791 in cash out of Polarean and in 2022 the Board took $ 955,144 in cash from funds which they didn't contribute compare that to the recent shares bought. The Board is committed to itself - they have just had an 18 month placing and watered all over long term shareholders. - and are reluctant to use the words shareholders or shareholder value. They almost all of them didn't own a single share between them until they waited until the share price was taken down by themselves to 1p when they could have raised in the previous 18 months. They have taken 956,879 in share based payments in 2023 and 943,507 in 2022. They now propose 181 million shares to motivate them. Just look at the BoD fees and salaries and ask yourself how that doesn't motivate them to get out of bed in the morning and work. The Board is committed to itself and is an absolute disgrace |
Posted at 09/7/2024 20:59 by goldbutler The share price graph shows the stock market reaction over the last 2 yearsand the market does not rate this Board Of Directors very highly. The CEO ex Brainsway just has to look at that share price graph not his Linkedin page. Chairman K West is taking every cent and dollar he can lay his hand on from Polarean and he is the Chairman responsible for the shambles since FDA approval. He has achieved almost nothing by way of sales in the last 18 months and the forecast from the company itself is not much better for the next 18 months. Nukem and Bracco have paid so little for the company they and the Board Minus the Director resignations must be delighted. No investormeet, no questions and no answers and UK shareholders can visit america again if the want to vote in a show of hands. |
Posted at 09/7/2024 20:48 by goldbutler The ' further news ' is$5.8 Million dollars has been taken in fees and share based payments and benefits by the Board of Directors of Polarean during the last 3 years. The share price graph shows the return to shareholders and the lack of any creation of shareholder value. In cash Mr West has taken $165,003 and Mr Laucht $131,250 during the same period. Almost the same amount the entire Board decided to invest in the recent 18 month long placing at 1p. The Directors are looking after themselves. 181 million shares in 2 weeks time required to 'motivate' them. |
Posted at 27/6/2024 11:45 by goldbutler Is AIM going to suspend trading in Polarean shares.The CEO and Chairman and BoD have just over 24 hours to decide just how to approach their shareholders. Annual report and accounts required. Annual reporting AIM Rule 19 requires that audited accounts are prepared within six months of the year end. Reporting of price sensitive information AIM Rule 11 requires notification without delay of any new developments which are not public knowledge which, if made public, would cause a significant movement in its share price. A request can be made for an extension of the time limits such as London stock exchange outlined on 21 jan 2021 |
Posted at 20/6/2024 10:46 by kingston78 I think that the two largest shareholders / backers of the company will, at an opportune time, engineer a bid for POLX by a larger group. They will clobber their shareholdings, together with recommendation by the directors, agree to a sale of the company at an attractive price.Digressing a little, private equity consortium has had their bid offers for Hargreaves Landsdown refused twice. But the directors will agree to a much higher offer of £5.4 billion for HL. The same thing will happen to POLX in my opinion, at 10 p each share when the company has won sufficient number of users for its products. There will be a push for worldwide offering. You just need to look at the historical share chart to see how much the company will claw back in terms of share price. A bid or not, there is a compelling business case for the share price to go higher. |
Posted at 29/5/2024 05:04 by bones698 Cash burn is around $600k a month so they have around 18 months of cash at best. Given the slow progress and uptick in revenues they are going to have to do a lot better in the coming months to get anywhere near that figure before the cash runs out again. Given the low deal values we have seen from deals here I remain unconvinced about this as a viable business. They have bought some time for sure at a very heavy price to investors but I don't see too much to be positive about so far.I also remain skeptical that the cash burn is a lot higher than the figure I used going off past losses but have used the most recent figure I can find in the update. Banding out figures of double the share price etc based on nothing is merely wishful thinking From update Profitability projected for late 2027, post-gas exchange FDA approval o Total of $30m to $35m, inclusive of money raised in the anticipated 2024 financing, from investment and strategic deals needed to fund the Company to profitability, investment focused on The above shows how far Polx is away from break even and will need.alot more money going forward to get there. It doesn't look a sound investment at all whje you consider the losses and monies required. Still there are plenty of gamblers around on these shares. |
Posted at 18/5/2024 13:19 by goldbutler CEODr C von Jako Shares bought NONE Shareholder No CFO C Osborne Shares bought NONE Shareholder No Directors non ex Juergen Laucht Shares bought NONE Shareholder No Frank Schulkes Shares bought NONE Shareholder No Marcella Ruddy Shares bought NONE Shareholder No Dan Brague Shares bought NONE Shareholder No Bill Blair Shares bought NONE Shareholder No Bastiaan Driehuys Shareholder Yes shares bought at last placing 2021 None Chairman Ken West Shareholder Yes shares bought at last placing 2021 None Mr Cyrille Petit rep of Bracco Shareholder Yes Shares bought at last placing Yes All ( with the exception of Mr Petit) non executives are pocketing director fees over a number of years. None of it is being invested in Polarean shares. Chairman Mr West has his hands firmly in Polarean's pockets and his own and has received plenty of fees none used to buy shares in Polarean with exception of his 10 year options extension. He didn't even buy at the last placing 2021. Mr Brague director with his cool $100000 max special marketing adviser money has not bought a single share. No investormeet scheduled nearly 9 months since the last one No AGM held in the UK to question the directors. Not much mention of shareholders since previous chairman Mr Allis left or Mr Hullihen both of whom were shareholders and bought at the last placing. |
Posted at 14/2/2024 17:05 by goldbutler polx 7.0pThe share price graph tells all here. The stock market value of this company was between 50 - 100 million for many years. Criticism of 'the market' on this board , was that it didn't know how to value such companies - utter rubbish of course . The share price graph tells all - it is a reflection of all the players in the market view of the Board of Directors utter failure to use £27million to deliver any commercial traction to date. Investors stung for money by USA based Directors Brokers figures of sales and equipment in use of 6 then 24 then 48 for the years 21 to 23E have not been delivered by Polarean directors. In the meantime they and all their employees are paid very well Asset managers are left wondering not about the technology but about those running the company. So commercial traction where is it from the Chairman and the CCO Mr Dusek and Mr Brague with his cool $100000 for refining a strategy - which really should have been developed when they had 27million to play with. Time to deliver Polarean Directors and that means for all shareholders. Commercial traction and partnerships deals required. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
